Nipro Corporation (TYO:8086)

Market Cap	214.72B
Revenue (ttm)	644.59B
Net Income (ttm)	5.11B
Shares Out	163.10M
EPS (ttm)	27.78
PE Ratio	47.39
Forward PE	20.71
Dividend	28.00 (2.15%)
Ex-Dividend Date	Mar 28, 2025

Volume	378,200
Average Volume	563,565
Open	1,312.50
Previous Close	1,316.50
Day's Range	1,304.00 - 1,318.50
52-Week Range	1,171.00 - 1,505.50
Beta	0.03
RSI	67.79
Earnings Date	Aug 8, 2025

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ products, functional products, dialysis products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products. This business also operates dialysis and training centers. The company’s Pharmaceutical-Related bu...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1947
• Employees: 38,117
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 8086

Financial Performance

In 2024, Nipro's revenue was 644.59 billion, an increase of 9.85% compared to the previous year's 586.79 billion. Earnings were 5.11 billion, a decrease of -53.97%.